rs1799800
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005236.3(ERCC4):c.1905-28G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.263 in 1,430,286 control chromosomes in the GnomAD database, including 51,599 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.23 ( 4292 hom., cov: 33)
Exomes 𝑓: 0.27 ( 47307 hom. )
Consequence
ERCC4
NM_005236.3 intron
NM_005236.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.64
Publications
18 publications found
Genes affected
ERCC4 (HGNC:3436): (ERCC excision repair 4, endonuclease catalytic subunit) The protein encoded by this gene forms a complex with ERCC1 and is involved in the 5' incision made during nucleotide excision repair. This complex is a structure specific DNA repair endonuclease that interacts with EME1. Defects in this gene are a cause of xeroderma pigmentosum complementation group F (XP-F), or xeroderma pigmentosum VI (XP6).[provided by RefSeq, Mar 2009]
ERCC4 Gene-Disease associations (from GenCC):
- xeroderma pigmentosum group FInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
- Fanconi anemia complementation group QInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- XFE progeroid syndromeInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 16-13944695-G-A is Benign according to our data. Variant chr16-13944695-G-A is described in ClinVar as Benign. ClinVar VariationId is 1229533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERCC4 | NM_005236.3 | c.1905-28G>A | intron_variant | Intron 9 of 10 | ENST00000311895.8 | NP_005227.1 | ||
| ERCC4 | XM_011522424.4 | c.2043-28G>A | intron_variant | Intron 10 of 11 | XP_011520726.1 | |||
| ERCC4 | XM_047433774.1 | c.1116-28G>A | intron_variant | Intron 6 of 7 | XP_047289730.1 | |||
| ERCC4 | XM_011522427.2 | c.555-28G>A | intron_variant | Intron 4 of 5 | XP_011520729.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.229 AC: 34854AN: 151938Hom.: 4289 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
34854
AN:
151938
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.240 AC: 60105AN: 250470 AF XY: 0.247 show subpopulations
GnomAD2 exomes
AF:
AC:
60105
AN:
250470
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.267 AC: 340803AN: 1278230Hom.: 47307 Cov.: 18 AF XY: 0.268 AC XY: 173139AN XY: 645940 show subpopulations
GnomAD4 exome
AF:
AC:
340803
AN:
1278230
Hom.:
Cov.:
18
AF XY:
AC XY:
173139
AN XY:
645940
show subpopulations
African (AFR)
AF:
AC:
4852
AN:
29990
American (AMR)
AF:
AC:
6426
AN:
44446
Ashkenazi Jewish (ASJ)
AF:
AC:
7304
AN:
24974
East Asian (EAS)
AF:
AC:
9011
AN:
38874
South Asian (SAS)
AF:
AC:
20797
AN:
82432
European-Finnish (FIN)
AF:
AC:
11951
AN:
53286
Middle Eastern (MID)
AF:
AC:
1863
AN:
5404
European-Non Finnish (NFE)
AF:
AC:
264395
AN:
944522
Other (OTH)
AF:
AC:
14204
AN:
54302
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
12411
24822
37232
49643
62054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8164
16328
24492
32656
40820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.229 AC: 34874AN: 152056Hom.: 4292 Cov.: 33 AF XY: 0.227 AC XY: 16851AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
34874
AN:
152056
Hom.:
Cov.:
33
AF XY:
AC XY:
16851
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
6780
AN:
41468
American (AMR)
AF:
AC:
2785
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
987
AN:
3464
East Asian (EAS)
AF:
AC:
1259
AN:
5176
South Asian (SAS)
AF:
AC:
1179
AN:
4822
European-Finnish (FIN)
AF:
AC:
2421
AN:
10564
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18542
AN:
67956
Other (OTH)
AF:
AC:
555
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1393
2786
4178
5571
6964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
944
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
XFE progeroid syndrome Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fanconi anemia complementation group Q Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Xeroderma pigmentosum, group F Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.